101 | 6F5Q |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
2-[2-(methylsulfonylamino)ethylamino]pyridine-4-carboxylic acid |
CTK |
|
0.68 |
SHOW |
102 | 6F5T |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
~{N}-oxidanyl-4-(2~{H}-1,2,3,4-tetrazol-5-yl)pyridine-2-carboxamide |
CQK |
|
0.68 |
SHOW |
103 | 6H4R |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-[2-[4-[4-[2-(dimethylamino)ethyl]phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FQB |
|
0.68 |
SHOW |
104 | 5FP4 |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
3-(4-phenylbutanoylamino)pyridine-4-carboxylic acid |
YC8 |
|
0.67 |
SHOW |
105 | 6H4T |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-(2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylethyl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FOW |
|
0.67 |
SHOW |
106 | 6H4S |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-[2-[4-[3-[2-(dimethylamino)ethyl]phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FQE |
|
0.67 |
SHOW |
107 | 6H4W |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-[2-[4-(3-chlorophenyl)-4-methyl-piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FQQ |
|
0.67 |
SHOW |
108 | 6DQE |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
2-(5-phenyl-4-{(R)-phenyl[2-(piperidin-1-yl)ethoxy]methyl}-1H-pyrazol-1-yl)pyridine-4-carboxylic acid |
H6A |
|
0.67 |
SHOW |
109 | 6H4Y |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-[2-[4-[4-(2-morpholin-4-ylethyl)phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FO8 |
|
0.67 |
SHOW |
110 | 2W2I |
Lysine-specific demethylase 4E | Homo sapiens |
B2RXH2 (KDM4E_HUMAN) |
PYRIDINE-2,4-DICARBOXYLIC ACID |
PD2 |
|
0.67 |
SHOW |
111 | 6H4V |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-(1-cyclopentylpiperidin-4-yl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FQN |
|
0.67 |
SHOW |
112 | 6H4U |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
8-[4-(1-methylpiperidin-4-yl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FO2 |
|
0.67 |
SHOW |
113 | 6DQF |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
2-{1-[2-(piperidin-1-yl)ethyl]-1H-benzimidazol-2-yl}thieno[3,2-b]pyridine-7-carboxylic acid |
H61 |
|
0.66 |
SHOW |
114 | 6F5S |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
~{N}-(3-morpholin-4-ylpropyl)-4-(2~{H}-1,2,3,4-tetrazol-5-yl)pyridine-2-carboxamide |
CQT |
|
0.66 |
SHOW |
115 | 6ETG |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
[[4-(2~{H}-1,2,3,4-tetrazol-5-yl)phenyl]carbonylamino]azanium |
BWT |
|
0.66 |
SHOW |
116 | 6RBI |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
5-(1~{H}-1,2,3,4-tetrazol-5-yl)quinolin-8-ol |
JX8 |
|
0.66 |
SHOW |
117 | 6H52 |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
8-[4-(1-cyclopentylpiperidin-4-yl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FQN |
|
0.65 |
SHOW |
118 | 6H4Z |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
8-[4-[2-[4-(3-chlorophenyl)piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one |
FQ5 |
|
0.63 |
SHOW |
119 | 6EJ1 |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
5-[1-[1-(2-chloranylethanoyl)piperidin-4-yl]pyrazol-4-yl]-7-oxidanylidene-6-propan-2-yl-4~{H}-pyrazolo[1,5-a]pyrimidine-3-carbonitrile |
B7Q |
|
0.63 |
SHOW |
120 | 6EIU |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
8-oxidanyl-6-phenyl-7-propan-2-yl-imidazo[1,2-b]pyridazine-3-carbonitrile |
B6T |
|
0.63 |
SHOW |
121 | 6EJ0 |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
7-oxidanylidene-6-propan-2-yl-5-[1-(1-prop-2-enoylpiperidin-4-yl)pyrazol-4-yl]-6~{H}-pyrazolo[1,5-a]pyrimidine-3-carbonitrile |
B7K |
|
0.62 |
SHOW |
122 | 6DQC |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
2-[4-{[2-(dimethylamino)ethyl](ethyl)carbamoyl}-5-(4-methoxyphenyl)-1H-pyrazol-1-yl]pyridine-4-carboxylic acid |
H5Y |
|
0.61 |
SHOW |
123 | 6BH4 |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
5-(1-tert-butyl-1H-pyrazol-4-yl)-7-oxo-6-(propan-2-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile |
DQS |
|
0.59 |
SHOW |
124 | 6CG1 |
Lysine-specific demethylase 4A | Homo sapiens |
O75164 (KDM4A_HUMAN) |
3-{[(4-fluorophenyl)methyl]amino}pyridine-4-carboxylic acid |
QC1 |
|
0.59 |
SHOW |
125 | 5IVE |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
5-methyl-7-oxo-6-(propan-2-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile |
6E8 |
|
0.58 |
SHOW |
126 | 5FZH |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
(3R)-5-fluoro-3-hydroxy-1,3-dihydro-2H-indol-2-one |
0TI |
|
0.58 |
SHOW |
127 | 5FYU |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
(3R)-3-azanyl-4-methyl-1,3-dihydroindol-2-one |
BY4 |
|
0.57 |
SHOW |
128 | 5CEH |
Lysine-specific demethylase 5A | Homo sapiens |
P29375 (KDM5A_HUMAN) |
7-oxo-5-phenyl-6-(propan-2-yl)-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile |
50P |
|
0.54 |
SHOW |
129 | 5LWB |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
5-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-7-oxidanylidene-6-propan-2-yl-6~{H}-pyrazolo[1,5-a]pyrimidine-3-carbonitrile |
79H |
|
0.48 |
SHOW |
130 | 6A55 |
Novel protein with potential Cupin domain | Pelagibacter ubique |
Q4FNM4 (Q4FNM4_PELUB) |
3-(dimethyl-lambda~4~-sulfanyl)propanoic acid |
DQY |
|
0.47 |
SHOW |
131 | 6QVO |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
N6-METHYL-DEOXY-ADENOSINE-5'-MONOPHOSPHATE |
6MA |
|
0.45 |
SHOW |
132 | 6EIY |
Lysine-specific demethylase 5B | Homo sapiens |
Q9UGL1 (KDM5B_HUMAN) |
2-chloranyl-~{N}-[2-[4-(3-cyano-7-oxidanylidene-6-propan-2-yl-4~{H}-pyrazolo[1,5-a]pyrimidin-5-yl)pyrazol-1-yl]ethyl]ethanamide |
B6W |
|
0.45 |
SHOW |
133 | 6US3 |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
N-[5-(2,3-dimethylphenyl)-1,6-naphthyridin-7-yl]acetamide |
8JF |
|
0.44 |
SHOW |
134 | 6W4Y |
Human lambda-6A light chain JTO | Homo sapiens |
- |
2-[(4~{R})-4-(2-methylpropyl)-2,5-bis(oxidanylidene)imidazolidin-1-yl]-~{N}-[4-(trifluoromethyl)phenyl]ethanamide |
7ZW |
|
0.44 |
SHOW |
135 | 6US2 |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
N-[5-(2,3-dimethylphenyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-7-yl]acetamide |
S3O |
|
0.44 |
SHOW |
136 | 6US4 |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
5-(2,3-dichlorophenyl)[1,2,4]triazolo[1,5-a]pyridin-2-amine |
GN6 |
|
0.44 |
SHOW |
137 | 6ETT |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
ethyl 2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoate |
BXH |
|
0.43 |
SHOW |
138 | 4CKR |
Epithelial discoidin domain-containing receptor 1 | Homo sapiens |
Q08345 (DDR1_HUMAN) |
4-[(4-ethylpiperazin-1-yl)methyl]-n-{4-methyl-3-[(2-oxo-2,3-dihydro-1h-indol-5-yl)oxy]phenyl}-3-(trifluoromethyl)benzamide |
DI1 |
|
0.43 |
SHOW |
139 | 6IMZ |
7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens |
P36639 (8ODP_HUMAN) |
3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine |
VGH |
|
0.43 |
SHOW |
140 | 4ALX |
Acetylcholine-binding protein | Lymnaea stagnalis |
P58154 (ACHP_LYMST) |
(4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one |
IZN |
|
0.43 |
SHOW |
141 | 4K3H |
Immunoglobulin lambda variable domain L5(L89S) | Homo sapiens |
- |
4-{bis[4-(dimethylamino)phenyl]methyl}phenol |
1OM |
|
0.42 |
SHOW |
142 | 4LA3 |
Dimethylsulfonioproprionate lyase DddQ | Ruegeria lacuscaerulensis |
D0CY60 (DDDQ_RUELI) |
3-(dimethyl-lambda~4~-sulfanyl)propanoic acid |
DQY |
|
0.41 |
SHOW |
143 | 5CFB |
Glycine receptor subunit alpha-3 | Homo sapiens |
O75311 (GLRA3_HUMAN) |
STRYCHNINE |
SY9 |
|
0.41 |
SHOW |
144 | 4FRR |
Soluble acetylcholine receptor | Aplysia californica |
Q8WSF8 (Q8WSF8_APLCA) |
3-[(2S)-azetidin-2-ylmethoxy]-5-[(1S,2R)-2-(2-methoxyethyl)cyclopropyl]pyridine |
0VC |
|
0.41 |
SHOW |